Generics 14

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Rizatriptan manufacturers

14 products found

Filters

14 products found

rizatriptan

Tablets, orally disintegrating (ODT) 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Vietnam , Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Italy , Latvia , Liechtenstein , Luxembourg , Lithuania , Malta , Netherlands , Norway , Poland , Portugal , Spain , Sweden , United Kingdom
Available for
Licensing with supply, Distribution only
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

rizatriptan

Tablets, orally disintegrating (ODT) 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 13 days

rizatriptan

Tablets, orally disintegrating (ODT) 5mg, 10mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Germany , Slovakia , Czech Republic , Poland , Romania , Netherlands
Manufacturer #6978
This global pharmaceutical company specializes in branded and generic medications, offering a wide range of products across various therapeutic areas including dermatology, oncology, and respiratory therapy. They prioritize quality manufacturing with GMP certifications and hold several patents for their innovative drug formulations. The company boasts a strong global presence spanning North America, Europe, Asia, Africa, Latin America, and the Middle East, with multiple manufacturing facilities strategically located in key regions. Their commitment to research and development is evident through dedicated R&D centers focused on advancing therapies and improving patient care worldwide.

Manufacturer usually replies in 4 days

Want to see all 14 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible